Scribd Logo
Upload

Welcome to Scribd!

  • ALPCO To Exhibit at The AACC's 70th Annual Scientific Meeting and Clinical Lab Expo

    Uploaded by

    PR.com
    17 views3 pages
    ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo.

    Original Title

    ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo

    Copyright

    © © All Rights Reserved

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    17 views3 pages

    ALPCO To Exhibit at The AACC's 70th Annual Scientific Meeting and Clinical Lab Expo

    Uploaded by

    PR.com
    ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    of 3

    ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical

    Lab Expo

    ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well
    as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay
    qualification program at AACC’s 70th Annual Clinical Lab Expo.

    Salem, NH, July 25, 2018 --(PR.com)-- ALPCO, a leading producer of research and clinical
    immunoassays, announced it will exhibit at the AACC's 70th Annual Clinical Lab Expo July 31 - August
    2, 2018 in Chicago, IL. The company will promote a number of tools to help research and improve
    clinical outcomes as well as increase laboratory efficiency.

    Among these tools are new and upcoming additions to ALPCO's STELLUX® Chemiluminescence
    product line including fecal calprotectin, active GLP-1 (7-36) amide, and glucagon ELISAs. ALPCO is
    currently conducting ongoing clinical studies with the STELLUX® Chemiluminescence Calprotectin
    ELISA to establish the kit as a future tool for the diagnosis of Crohn's disease and ulcerative colitis.

    ALPCO will also promote its comprehensive therapeutic drug monitoring portfolio consisting of ten
    colorimetric ELISAs. The therapeutic drug monitoring assays offer a reliable method to research optimal
    concentrations, immune responses, and the influence of anti-drug antibodies on biologics which can lead
    to improving clinical outcomes for inflammatory bowel disease.

    Laboratory professionals can visit ALPCO at the Clinical Lab Expo to learn about maximizing lab
    productivity with ALPCO's complete gastroenterology ELISA testing panel and the FDA Class I Exempt
    Easy Stool Extraction Device. By using both tools together, lab technicians can replace manual weighing
    with one simple extraction step, while increasing the efficiency and reliability of measuring biomarkers
    such as pancreatic elastase-1.

    In addition, AACC Clinical Lab Expo attendees can learn about ALPCO's assay qualification program
    which assists laboratories with transitioning to in-house testing.

    “Our assay qualification program was developed to help institutions save time and ease the burden of
    onboarding new tests,” said ALPCO President Sean Conley. “Ultimately, our aim is to allow for savings
    that will result in lower overall healthcare costs in the industry.”

    Visit ALPCO in booth 3467 at the AACC's 70th Annual Clinical Lab Expo to learn more about these
    tools and services to help improve clinical outcomes and increase productivity in the lab.

    About ALPCO
    American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of
    immunoassay-based products for the North American life science markets. The company has since grown
    into a premier channel representing over 60 collaborating partners from around the globe. Today, ALPCO
    offers a wide range of testing solutions, providing scientists and healthcare professionals with vital tools

    Page 1/3
    PR.com Press Release Distribution Terms of Use
    for advancing research and improving quality of care.

    Page 2/3
    PR.com Press Release Distribution Terms of Use
    Contact Information:
    ALPCO
    Bethany Bell, PhD
    1-800-592-5726
    Contact via Email
    www.alpco.com

    Online Version of Press Release:


    You can read the online version of this press release at: https://www.pr.com/press-release/760393

    News Image:

    Page 3/3
    PR.com Press Release Distribution Terms of Use

    You might also like